300583 赛托生物
2024/09 - 九个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)0.7442.4442.4672.177-10.350
总资产报酬率 ROA (%)0.4651.4631.4071.246-6.170
投入资产回报率 ROIC (%)0.5121.6621.6511.456-7.223

边际利润分析
销售毛利率 (%)26.38422.31220.79222.08411.784
营业利润率 (%)2.7692.5583.7524.654-20.385
息税前利润/营业总收入 (%)5.9507.0906.3276.971-17.277
净利润/营业总收入 (%)1.7263.7933.2362.976-20.764

收益指标分析
经营活动净收益/利润总额(%)97.80466.44493.42494.45462.349
价值变动净收益/利润总额(%)52.4236.75416.6897.312-4.722
营业外收支净额/利润总额(%)-2.16038.783-2.743-3.1023.269

偿债能力分析
流动比率 (X)1.3791.4171.0511.0241.214
速动比率 (X)0.6710.6840.4900.5200.648
资产负债率 (%)35.25836.25640.88641.67740.472
带息债务/全部投入资本 (%)29.33528.15032.58532.046--
股东权益/带息债务 (%)233.475245.515204.788209.471204.193
股东权益/负债合计 (%)178.473171.277140.442135.957142.881
利息保障倍数 (X)1.8362.4352.3652.837-4.550

营运能力分析
应收账款周转天数 (天)87.97765.92053.65244.2080.000
存货周转天数 (天)338.664240.947197.357204.3240.000